Cargando…

Barriers for Sports and Exercise Participation and Corresponding Barrier Management in Cystic Fibrosis

Background: Nowadays physical activity (PA)/exercise is an important component of cystic fibrosis (CF) therapy. The aim of the study was to assess the barriers to PA and the barrier management and to explore the effect of supervision on the barriers and barrier management during an exercise program....

Descripción completa

Detalles Bibliográficos
Autores principales:	Dillenhoefer, Stefanie, Stehling, Florian, Welsner, Matthias, Schlegtendal, Anne, Sutharsan, Sivagurunathan, Olivier, Margarete, Taube, Christian, Mellies, Uwe, Koerner-Rettberg, Cordula, Brinkmann, Folke, Gruber, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603748/ https://www.ncbi.nlm.nih.gov/pubmed/36293733 http://dx.doi.org/10.3390/ijerph192013150

Ejemplares similares

Long-Term Follow-Up of Health-Related Quality of Life and Short-Term Intervention with CFTR Modulator Therapy in Adults with Cystic Fibrosis: Evaluation of Changes over Several Years with or without 33 Weeks of CFTR Modulator Therapy
por: Gruber, Wolfgang, et al.
Publicado: (2023)

Trainability of Health-Related and Motor Performance Fitness in Adults with Cystic Fibrosis within a 12-Month Partially Supervised Exercise Program
por: Welsner, Matthias, et al.
Publicado: (2021)

Effects of a Long-Term Monitored Exercise Program on Aerobic Fitness in a Small Group of Children with Cystic Fibrosis
por: Gruber, Wolfgang, et al.
Publicado: (2022)

Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
por: Dietz-Terjung, Sarah, et al.
Publicado: (2020)

Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
por: Dietz-Terjung, Sarah, et al.
Publicado: (2020)

Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult Care
por: Welsner, Matthias, et al.
Publicado: (2019)

How personality influences health outcomes and quality of life in adult patients with cystic fibrosis
por: Niehammer, Ute, et al.
Publicado: (2023)

Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2023)

Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
por: Niehammer, Ute, et al.
Publicado: (2022)

Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
por: Olivier, Margarete, et al.
Publicado: (2023)

Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T – a case report
por: Welsner, Matthias, et al.
Publicado: (2019)

Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system
por: Straßburg, Svenja, et al.
Publicado: (2022)

Impaired Nitric Oxide Synthetase Activity in Primary Ciliary Dyskinesia—Data-Driven Hypothesis
por: Eggenkemper, Lisa, et al.
Publicado: (2023)

Obstructive sleep apnea and nocturnal hypoxemia in adult patients with cystic fibrosis
por: Welsner, Matthias, et al.
Publicado: (2022)

An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2020)

Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy
por: Westhölter, Dirk, et al.
Publicado: (2023)

Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy
por: Koerner-Rettberg, Cordula, et al.
Publicado: (2014)

Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection
por: Steindor, Mathis, et al.
Publicado: (2021)

Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
por: Grosse-Onnebrink, Joerg, et al.
Publicado: (2017)

Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients
por: Stehling, Florian, et al.
Publicado: (2017)

Coil embolisation for massive haemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2021)

Pulmonary Function and Long-Term Respiratory Symptoms in Children and Adolescents After COVID-19
por: Knoke, Leona, et al.
Publicado: (2022)

Multiplex PCR of bronchoalveolar lavage fluid in children enhances the rate of pathogen detection
por: Tschiedel, Eva, et al.
Publicado: (2019)

Reduced Lung Function in a Chronic Asthma Model Is Associated with Prolonged Inflammation, but Independent of Peribronchial Fibrosis
por: Koerner-Rettberg, Cordula, et al.
Publicado: (2008)

Characterization of the L-Arginine/Nitric Oxide Pathway and Oxidative Stress in Pediatric Patients with Atopic Diseases
por: Hanusch, Beatrice, et al.
Publicado: (2022)

To Mask or Not to Mask—Evaluation of Cognitive Performance in Children Wearing Face Masks during School Lessons (MasKids)
por: Schlegtendal, Anne, et al.
Publicado: (2022)

Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
por: Junge, Sibylle, et al.
Publicado: (2016)

Somatosensory abnormalities after infection with SARS-CoV-2 – A prospective case-control study in children and adolescents
por: Eitner, Lynn, et al.
Publicado: (2022)

Disparities in Youth Sports and Barriers to Participation
por: Pandya, Nirav Kiritkumar
Publicado: (2021)

Bronchial artery diameter in massive hemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2022)

Seroconversion rate and socio-economic and ethnic risk factors for SARS-CoV-2 infection in children in a population-based cohort, Germany, June 2020 to February 2021
por: Brinkmann, Folke, et al.
Publicado: (2022)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier properties
por: Bierbaumer, Lisa, et al.
Publicado: (2018)

Longitudinal Rise in Seroprevalence of SARS-CoV-2 Infections in Children in Western Germany—A Blind Spot in Epidemiology?
por: Brinkmann, Folke, et al.
Publicado: (2021)

Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia
por: Kattner, Simone, et al.
Publicado: (2023)

Opportunities and Barriers to Medication Safety in Community-Dwelling Older Adults
por: Jallow, Fatoumata, et al.
Publicado: (2021)

Practical barriers and corresponding solutions in applying interrupted time series to PUMA
por: Huang, Chao, et al.
Publicado: (2015)

The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo
por: Beyer, Marc, et al.
Publicado: (2005)

Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study
por: Goss, Christopher H., et al.
Publicado: (2022)

Barriers to voluntary participation in sport for children: a systematic review
por: Somerset, Sarah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ft4u5cl3a1dglgjjgeg990kfj0